Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 05, 2015 08:00 ET | Source: Inform Genomics

Inform Genomics Files Provisional Patent Application with United States Patent and Trademark Office (USPTO) -"Systems and Methods for Predicting Treatment-Regimen-Related Outcomes."

Boston, Oct. 5, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine products announced...
June 01, 2015 08:30 ET | Source: Inform Genomics

Inform Genomics Licenses Two US Patents from Taiwan's National Cheng Kung University to Advance Development of Precision Medicine Products

Boston, MA, June 1, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine products, and...
June 01, 2015 08:00 ET | Source: Inform Genomics

Inform Genomics Selects ICON as Contract Research Organization (CRO) for Pivotal Multicenter Study of HSCT/Mucositis Product Candidate

Boston, MA, June 1, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine products, today...
May 29, 2015 16:00 ET | Source: Inform Genomics

Inform Genomics Selects US Oncology Research as the Site Management Organization (SMO) for Pivotal Multicenter Study of OnPART

Boston, MA, May 29, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to discover and develop genomic-based, precision medicine...
May 29, 2015 08:00 ET | Source: Inform Genomics

Inform Genomics Selects Vector Oncology as Contract Research Organization (CRO) for Pivotal Multicenter Study of OnPART

Boston, MA and Memphis, TN, May 29, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine...
July 28, 2014 08:00 ET | Source: Inform Genomics

Inform Genomics Announces Appointment of Carl de Moor, PhD, as Chief Technology Officer

Boston, MA, July 28, 2014 (GLOBE NEWSWIRE) -- Inform Genomics, Inc, a privately held company that utilizes a proprietary technology platform to discover and develop genomic-based, precision medicine...
June 23, 2014 07:00 ET | Source: Inform Genomics

Inform Genomics and Translational Drug Development (TD2) Announce Strategic Collaboration

BOSTON, June 23, 2014 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary technology platform to discover and develop genomic-based, precision medicine...
October 15, 2013 07:00 ET | Source: Inform Genomics

INFORM GENOMICS and TESARO Enter Into Collaboration Agreement

Boston, MA, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a private company focused on developing novel platforms of genomic-based, personalized medicine products for cancer supportive...
June 03, 2013 08:00 ET | Source: Inform Genomics

Inform Genomics Presents Biologic Validity for OnPART Predictive Networks Identifying Potential Genomic Targets for Drug Discovery

Boston, MA, June 3, 2013 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a private company focused on developing novel platforms of genomic-based personalized medicine products for cancer supportive...
January 28, 2013 07:00 ET | Source: Inform Genomics

Inform Genomics Presents Results for OnPART(tm) Showing High Degree of Accuracy Predicting Six Common Side Effects of FOLFOX Chemotherapy for Colon Cancer

Boston, MA, Jan. 28, 2013 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a private company focused on developing novel platforms of genomic-based personalized medicine products for cancer supportive...

Next Page keyboard_arrow_right